Immuneering Corporation Capital Expenditures
Immuneering Corporation (IMRX) reported Capital Expenditures of $107.30 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- Immuneering Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $27.37K, a 1193.34% increase year-over-year.
- Immuneering Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $79.93K, a 793.57% increase year-over-year.
- Immuneering Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $123.91K, a 1224.39% increase year-over-year.
- Immuneering Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $7.25K, a 37.72% increase year-over-year.
- Immuneering Corporation payments to acquire property, plant, and equipment for fiscal 2025 was $142.23K, a 67.57% increase from fiscal 2024.
- Immuneering Corporation payments to acquire property, plant, and equipment for fiscal 2024 was $84.88K, a 75.24% decline from fiscal 2023.
- Immuneering Corporation payments to acquire property, plant, and equipment for fiscal 2023 was $342.75K, a 53.84% decline from fiscal 2022.
- Immuneering Corporation payments to acquire property, plant, and equipment for fiscal 2022 was $742.48K, a 1121.47% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $107.30K 10-Q · filed 2026-08-05 | $231.21K derived: sum of 3 quarters · filed 2026-08-05 | $238.46K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $79.93K 10-Q · filed 2026-05-15 | $203.84K derived: sum of 2 quarters · filed 2026-05-15 | $211.09K derived: sum of 3 quarters · filed 2026-05-15 | $213.21K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $123.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $131.16K derived: sum of 2 quarters · filed 2026-03-06 | $133.28K derived: sum of 3 quarters · filed 2026-08-05 | $142.23K 10-K · filed 2026-03-06 |
| 2025-09-30 | $7.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $9.37K derived: sum of 2 quarters · filed 2026-08-05 | $18.32K 10-Q · filed 2025-11-12 | $27.67K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.06K 10-Q · filed 2026-08-05 | $20.42K derived: sum of 3 quarters · filed 2026-08-05 | $25.68K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $8.95K 10-Q · filed 2026-05-15 | $18.30K derived: sum of 2 quarters · filed 2026-05-15 | $23.57K derived: sum of 3 quarters · filed 2026-05-15 | $56.34K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $9.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $14.62K derived: sum of 2 quarters · filed 2026-03-06 | $47.40K derived: sum of 3 quarters · filed 2026-03-06 | $84.88K 10-K · filed 2026-03-06 |
| 2024-09-30 | $5.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $38.04K derived: sum of 2 quarters · filed 2025-11-12 | $75.52K 10-Q · filed 2025-11-12 | $246.44K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $32.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $70.25K 10-Q · filed 2025-08-13 | $241.17K derived: sum of 3 quarters · filed 2025-08-13 | $298.32K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $37.48K 10-Q · filed 2025-05-05 | $208.40K derived: sum of 2 quarters · filed 2025-05-05 | $265.55K derived: sum of 3 quarters · filed 2025-05-05 | $352.23K derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $170.92K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $228.07K derived: sum of 2 quarters · filed 2025-03-20 | $314.75K derived: sum of 3 quarters · filed 2025-03-20 | $342.75K 10-K · filed 2025-03-20 |
| 2023-09-30 | $57.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $143.84K derived: sum of 2 quarters · filed 2024-11-13 | $171.83K 10-Q · filed 2024-11-13 | $241.13K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $86.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $114.68K 10-Q · filed 2024-08-06 | $183.98K derived: sum of 3 quarters · filed 2024-08-06 | $577.12K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $27.99K 10-Q · filed 2024-05-07 | $97.30K derived: sum of 2 quarters · filed 2024-05-07 | $490.43K derived: sum of 3 quarters · filed 2024-05-07 | $655.43K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $69.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $462.44K derived: sum of 2 quarters · filed 2024-03-01 | $627.43K derived: sum of 3 quarters · filed 2024-03-01 | $742.48K 10-K · filed 2024-03-01 |
| 2022-09-30 | $393.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $558.13K derived: sum of 2 quarters · filed 2023-11-09 | $673.18K 10-Q · filed 2023-11-09 | $686.23K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $280.05K 10-Q · filed 2023-08-03 | $293.10K derived: sum of 3 quarters · filed 2023-08-03 | $304.44K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $115.05K 10-Q · filed 2023-05-04 | $128.10K derived: sum of 2 quarters · filed 2023-05-04 | $139.45K derived: sum of 3 quarters · filed 2023-05-04 | $159.27K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $13.05K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $24.40K derived: sum of 2 quarters · filed 2023-03-06 | $44.22K derived: sum of 3 quarters · filed 2023-03-06 | $60.79K 10-K · filed 2023-03-06 |
| 2021-09-30 | $11.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $31.17K derived: sum of 2 quarters · filed 2022-11-10 | $47.73K 10-Q · filed 2022-11-10 | $85.79K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $19.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $36.39K 10-Q · filed 2022-08-10 | $74.45K derived: sum of 3 quarters · filed 2022-08-10 | $80.05K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $16.56K 10-Q · filed 2022-05-10 | $54.62K derived: sum of 2 quarters · filed 2022-05-10 | $60.23K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $38.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $43.66K derived: sum of 2 quarters · filed 2022-03-10 | $53.41K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $5.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $15.36K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $9.75K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |